NEWS
Print Your Certificate
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Mohammed Aleskandarany
University of Derby - Derby / United Kingdom
Medical and Health Sciences / Pathology
AD Scientific Index ID: 1370318
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Mohammed Aleskandarany's MOST POPULAR ARTICLES
1-)
Triple-negative breast cancer: distinguishing between basal and nonbasal subtypesEA Rakha, SE Elsheikh, MA Aleskandarany, HO Habashi, AR Green, ...Clinical Cancer Research 15 (7), 2302-2310, 20096062009
2-)
Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifenHO Habashy, DG Powe, CM Staka, EA Rakha, G Ball, AR Green, ...Breast cancer research and treatment 119 (2), 283-293, 20102252010
3-)
CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcomeS Elsheikh, AR Green, MA Aleskandarany, M Grainge, CE Paish, ...Breast cancer research and treatment 109 (2), 325-335, 20081662008
4-)
Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancerMA Aleskandarany, AR Green, AA Benhasouna, FF Barros, K Neal, ...Breast Cancer Research 14, 1-11, 20121672012
5-)
MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroupsMA Aleskandarany, EA Rakha, RD Macmillan, DG Powe, IO Ellis, ...Breast cancer research and treatment 127, 591-599, 20111382011
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept